219 related articles for article (PubMed ID: 26661280)
1. Two cases of cutaneous leishmaniasis in Dutch military personnel treated with oral miltefosine.
van der Snoek EM; Couwenberg SM; Stijnis C; Kortbeek LM; Schadd EM
J R Army Med Corps; 2017 Feb; 163(1):68-70. PubMed ID: 26661280
[TBL] [Abstract][Full Text] [Related]
2. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent.
Soto J; Toledo J; Gutierrez P; Nicholls RS; Padilla J; Engel J; Fischer C; Voss A; Berman J
Clin Infect Dis; 2001 Oct; 33(7):E57-61. PubMed ID: 11528586
[TBL] [Abstract][Full Text] [Related]
3. Miltefosine for new world cutaneous leishmaniasis.
Soto J; Arana BA; Toledo J; Rizzo N; Vega JC; Diaz A; Luz M; Gutierrez P; Arboleda M; Berman JD; Junge K; Engel J; Sindermann H
Clin Infect Dis; 2004 May; 38(9):1266-72. PubMed ID: 15127339
[TBL] [Abstract][Full Text] [Related]
4. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
[TBL] [Abstract][Full Text] [Related]
5. Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.
Calvopina M; Gomez EA; Sindermann H; Cooper PJ; Hashiguchi Y
Am J Trop Med Hyg; 2006 Dec; 75(6):1074-7. PubMed ID: 17172368
[TBL] [Abstract][Full Text] [Related]
6. Oral miltefosine to treat new world cutaneous leishmaniasis.
Soto J; Toledo JT
Lancet Infect Dis; 2007 Jan; 7(1):7. PubMed ID: 17182338
[No Abstract] [Full Text] [Related]
7. First case of typical Old World cutaneous leishmaniasis treated with miltefosine.
Stojkovic M; Junghanss T; Krause E; Davidson RN
Int J Dermatol; 2007 Apr; 46(4):385-7. PubMed ID: 17442078
[TBL] [Abstract][Full Text] [Related]
8. [Miltefosine: a new remedy for leishmaniasis].
Dorlo TP; Eggelte TA; Beijnen JH; de Vries PJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2697-701. PubMed ID: 17194005
[TBL] [Abstract][Full Text] [Related]
9. A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome.
Coelho AC; Oliveira JC; Espada CR; Reimão JQ; Trinconi CT; Uliana SR
PLoS Negl Trop Dis; 2016 May; 10(5):e0004660. PubMed ID: 27144739
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis.
Vélez I; López L; Sánchez X; Mestra L; Rojas C; Rodríguez E
Am J Trop Med Hyg; 2010 Aug; 83(2):351-6. PubMed ID: 20682881
[TBL] [Abstract][Full Text] [Related]
11. Treatment of leishmaniasis with miltefosine: 2008 status.
Berman JJ
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Miltefosine Failure and Spontaneous Resolution of Cutaneous Leishmaniasis braziliensis.
Joseph S; Whitman TJ; Buckner FS; Cogen AL
Am J Trop Med Hyg; 2021 May; 105(1):142-143. PubMed ID: 33970891
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.
van Thiel PP; Leenstra T; de Vries HJ; van der Sluis A; van Gool T; Krull AC; van Vugt M; de Vries PJ; Zeegelaar JE; Bart A; van der Meide WF; Schallig HD; Faber WR; Kager PA
Am J Trop Med Hyg; 2010 Dec; 83(6):1295-300. PubMed ID: 21118937
[TBL] [Abstract][Full Text] [Related]
14. Treatment of diffuse cutaneous leishmaniasis with miltefosine: a case report.
Zerpa O; Blanco B; Kannee C; Ulrich M; Sindermann H; Engel J; Convit J
Int J Dermatol; 2006 Jun; 45(6):751-3. PubMed ID: 16796642
[TBL] [Abstract][Full Text] [Related]
15. Miltefosine to treat cutaneous leishmaniasis caused by Leishmania tropica.
Killingley B; Lamb LE; Davidson RN
Ann Trop Med Parasitol; 2009 Mar; 103(2):171-5. PubMed ID: 19208301
[No Abstract] [Full Text] [Related]
16. Thermotherapy effective and safer than miltefosine in the treatment of cutaneous leishmaniasis in Colombia.
López L; Cruz C; Godoy G; Robledo SM; Vélez ID
Rev Inst Med Trop Sao Paulo; 2013; 55(3):. PubMed ID: 23740007
[TBL] [Abstract][Full Text] [Related]
17. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous leishmaniasis treatment.
Minodier P; Parola P
Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous leishmaniasis successfully treated with miltefosine.
Chan CX; Simmons BJ; Call JE; Yan S; Glass JS; Chapman MS
Cutis; 2020 Oct; 106(4):206-209. PubMed ID: 33186422
[TBL] [Abstract][Full Text] [Related]
20. Chronic cutaneous leishmaniasis in an immunocompetent patient: response to miltefosine.
Ruiz-Villaverde R; Sánchez-Cano D; Villaverde-Gutierrez C
J Eur Acad Dermatol Venereol; 2007 May; 21(5):695-6. PubMed ID: 17447994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
